This a strange one at this point - wonder if there is a partner in the wings ?
The main reason they were going to spin-off Phenomica was to try & partner with big pharma as bank.
Phenotypic screening was the bees knees but it also costs a lot more to carry out hence why they wanted big names to back into it ?
Ann: Europe Patent Phenotypic Screening, page-4
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.010(8.33%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.0¢ | 12.0¢ | $249.2K | 1.966M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 254743 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 242275 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |